CoChat

Medical Assistance in Dying for the Sole Underlying Condition of Mental Disorder (MAiD MD-SUMC): an analysis and qualitative evidence synthesis

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 30 of the 82 sources its claims cite were checked for support.

Abstract

Objectives: To synthesise existing qualitative and conceptual literature on the implementation, ethical considerations and policy implications of Medical Assistance in Dying for Mental Disorder as a Sole Underlying Medical Condition (MAiD MD-SUMC) in Canada and internationally. Design: A qualitative evidence synthesis using a thematic analysis approach. Empirical, conceptual and policy papers addressing MAiD for mental disorders were identified through major databases and grey literature. Studies were thematically analysed to identify recurring ethical, clinical and policy themes related to eligibility, assessment and implementation. Data sources: Data was extracted from a systematic search of Medline and Embase for peer-reviewed studies published from 1974 onwards, supplemented by relevant policy documents and legal cases. Eligibility criteria: Studies were included if they examined MAiD MD-SUMC and explored ethical, legal or clinical considerations or provided stakeholder perspectives. Exclusion criteria included studies focusing solely on non-psychiatric conditions or not published in English. Data extraction and synthesis: Two independent reviewers screened, extracted and analysed data using an iterative thematic synthesis approach. Key themes were identified through consensus discussions. Results: The synthesis identified four major themes: (1) Irremediability and treatment resistance—persistent uncertainty regarding when mental disorders can be considered irremediable. (2) Capacity and vulnerability—ongoing debate about assessing capacity amid fluctuating symptoms and social influences. (3) Ethical and policy considerations—divergent interpretations of autonomy, justice and safeguards highlighting the need for standardised criteria. (4) Public and professional perspectives—public and family support for inclusion, although clinician hesitancy exists. Conclusions: The evidence supports a thoughtful, structured approach to potential implementation of MAiD MD-SUMC in Canada. Future priorities include refining criteria for irremediability, standardising capacity assessments, addressing disorder-specific complexities and strengthening mental health infrastructure. Continued research, engagement and transparent policy dialogue will be essential to ensure that any expansion of MAiD upholds ethical integrity, protects vulnerable persons and maintains public trust.

Overview

CoChat Summary

TL;DR

This qualitative evidence synthesis of 59 articles plus six supplementary legal/policy sources maps ethical, clinical and policy themes for MAiD for mental disorder as the sole underlying medical condition (MAiD MD-SUMC), especially in Canada and permissive jurisdictions. It finds persistent uncertainty about irremediability and capacity, growing public and family support alongside clinician hesitancy, and calls for standardised safeguards, multidisciplinary assessment and stronger mental health infrastructure before implementation.

Key findings

  • The synthesis identified four major themes: irremediability and treatment resistance; capacity and vulnerability; ethical and policy considerations; and public and professional perspectives. Across 621 records identified, 234 duplicates removed, 387 screened, 66 full-text assessed and 59 articles included, plus six supplementary sources.
  • Irremediability was a negotiated concept rather than a fixed clinical category: no standardised criteria were found, Dutch psychiatrists varied in defining “incurability,” and treatment-resistant depression may still respond to psychotherapy, neuromodulation or ketamine. MAiD MD-SUMC remained a small proportion of overall requests, between 0% and 2% in a 2021 systematic review, while Canadian MAiD procedures rose from 1018 in 2016 to 7595 in 2021, and concurrent palliative care among MAiD recipients rose from 52% in 2016–2017 to 74% in 2024.
  • Capacity assessment was described as a central challenge, including distinguishing enduring requests from suicidality and accounting for fluctuating symptoms and social determinants such as isolation and access to care. Some patient and family interviews described long-standing, reflective decision-making rather than impulsive intent, and the Expert Panel on MAiD and Mental Illness advised that capacity can be established through understanding, appreciation, reasoning and voluntary choice with rigorous, repeated assessments.
  • Public and family attitudes were generally more supportive than provider views: 53% of Dutch respondents supported MAiD eligibility for psychiatric patients versus about one-third of US respondents, and a 2023 Dying with Dignity Canada survey reported 80% of Canadians supported inclusion of MAiD MD-SUMC. Families often described relief of suffering and dignity, while psychiatrists expressed greater hesitancy over prognostic uncertainty and assessment complexity.

Methods

  • Qualitative evidence synthesis using thematic analysis, reported with the ENTREQ checklist. Searches covered Medline and Embase for peer-reviewed English-language studies published from 1974 to May 2024, supplemented by policy documents and legal cases; inclusion required focus on MAiD MD-SUMC with ethical, legal, clinical or stakeholder perspectives, while non-psychiatric MAiD, non-English and non-peer-reviewed sources were excluded.
  • Two independent reviewers screened titles, abstracts and full texts, with discrepancies resolved by discussion or a third reviewer. Data were extracted on study, participant and key-finding characteristics.
  • Because sources were heterogeneous, the authors conducted a structured narrative overview rather than meta-ethnography or meta-aggregation, iteratively grouping concepts into thematic domains through team consensus and deliberately retaining divergent or minority perspectives. There was no patient or public involvement.

Limitations

  • Stated: restricting inclusion to peer-reviewed English-language sources and official English translations may have introduced language and jurisdictional bias, potentially underrepresenting countries where MAiD MD-SUMC is practised. The available literature was largely descriptive, conceptual or exploratory, with limited longitudinal or high-quality empirical data.
  • Stated: reliance on secondary published sources limits capture of lived experiences, emerging clinical practices and rapidly evolving policy, and may disproportionately reflect academic and policy-oriented perspectives. Heterogeneous source types created synthesis challenges, and thematic synthesis inherently involves interpretive judgement and subjective prioritisation; findings are time-specific.
  • Evident from the text: the review did not take a normative position on legislation, had no patient or public involvement, and did not use a formal meta-synthesis framework, which may further limit direct aggregation or generalisability of findings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2025-105129

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flow diagram of study selection for qualitative evidence synthesis on MAiD MD-SUMC. MAiD MD-SUMC, Medical Assistance in Dying for Mental Disorder as a Sole Underlying Medical Condition; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 1 PRISMA flow diagram of study selection for qualitative evidence synthesis on MAiD MD-SUMC. MAiD MD-SUMC, Medical Assistance in Dying for Mental Disorder as a Sole Underlying Medical Condition; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.CC BY-NC · PubMed Central

Verification

Claims the paper makes

24 Valid · 9 Not valid · 52 Not checked · 93 Own results and interpretations

53 more claims · 3 with their cited sources checked

Create a free account to see all 178 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 88
  • It may state two separate claims as one. 57
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. Veen, 2020, Irremediable Psychiatric Suffering in the Context of Physician-assisted Death: A Scoping Review of Arguments, Canadian J Psych, 65, 070674372092307

Metadata

Authors
Pawluk, A., Arksey, E., Jansens, H., Qiao, S., & McFarlane, L.
Affiliations
University of British Columbia (CA)
Corresponding author
Pawluk, Alicia
Venue
BMJ Open
Publisher
BMJ
Published
2026-05
Volume
16
Issue
5
Pages
e105129
ISSN
2044-6055 (ISSN-L)
OpenAlex
W7160180643
Cited by
0
References
46
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
Keywords
medical assistance in dying, mental illness, treatment resistance, capacity assessment, mental health policy, autonomy, justice, safeguards, mental health infrastructure, Canada
MeSH terms
Mental Disorders, Canada, Humans, Mental Competency, Suicide, Assisted, Qualitative Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medical Assistance in Dying for the Sole Underlying Condition of Mental Disorder (MAiD MD-SUMC): an analysis and qualitative evidence synthesis. https://app.cochat.ai/papers/10.1136/bmjopen-2025-105129
The paper
Pawluk, A., Arksey, E., Jansens, H., Qiao, S., & McFarlane, L. (2026). Medical Assistance in Dying for the Sole Underlying Condition of Mental Disorder (MAiD MD-SUMC): an analysis and qualitative evidence synthesis. BMJ Open. https://doi.org/10.1136/bmjopen-2025-105129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.